BrightBid Group AB (publ) - Asset Resilience Ratio
BrightBid Group AB (publ) (PERP-B) has an Asset Resilience Ratio of 9.71% as of June 2018. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See PERP-B current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2017–2017)
This chart shows how BrightBid Group AB (publ)'s Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see PERP-B asset base.
Liquid Assets Composition Over Time
This chart breaks down BrightBid Group AB (publ)'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read PERP-B total liabilities for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 0% |
| Short-term Investments | Skr1.99 Million | 9.71% |
| Total Liquid Assets | Skr1.99 Million | 9.71% |
Asset Resilience Insights
- Limited Liquidity: BrightBid Group AB (publ) maintains only 9.71% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
BrightBid Group AB (publ) Industry Peers by Asset Resilience Ratio
Compare BrightBid Group AB (publ)'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
TransMedics Group Inc
NASDAQ:TMDX |
Medical Devices | 0.00% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.84% |
|
Novocure Ltd
NASDAQ:NVCR |
Medical Devices | 43.72% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 34.37% |
|
Hangzhou AGS MedTech Co. Ltd. A
SHG:688581 |
Medical Devices | 18.80% |
|
Nanjing Vishee Medical Technology Co Ltd
SHG:688580 |
Medical Devices | 10.74% |
|
Nanjing Medlander Medical Technology Co. Ltd. A
SHG:688273 |
Medical Devices | 34.29% |
Annual Asset Resilience Ratio for BrightBid Group AB (publ) (2017–2017)
The table below shows the annual Asset Resilience Ratio data for BrightBid Group AB (publ).
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2017-12-31 | 52.03% | Skr7.99 Million ≈ $860.14K |
Skr15.36 Million ≈ $1.65 Million |
-- |
About BrightBid Group AB (publ)
Perpetua Medical AB (publ) provides products and solutions for use of injectable drugs in Sweden. It provides DrugLog, a solution for reducing medication errors in pharmacy; WasteLog, a device that analysis waste and returns of injectable controlled substances; and PrepLog, a DrugLog based technology platform that integrated prescription software or medication management system for the test of dr… Read more